Feasibility of personalized adiuvant chemotherapy of gastric cancer utilizing expression profiling, polymorphism and methylation of genes associated with metabolism and pharmacodynamics of cisplatin and fluorouracil
2011/01/B/NZ4/03692
Keywords
Descriptors
- NZ2_2: Genomika, transkryptomika i epigenomika
- NZ4_11: Biologia nowotworów
- NZ5_7: Leczenie chorób człowieka
Panel
NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution
Uniwersytet Jagielloński- Collegium Medicum, Wydział Lekarski
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 15
Call
OPUS 1 – announced on 2011-03-15
- Amount awarded
- 557 500 PLN
- Project start date
- 2011-12-16
- Project end date
- 2014-12-15
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Equipment purchased [PL]
- Termocykler 96 dołkowy do Real-Time PCR. Cost: 200 000 PLN
Information in the final report
Publication in academic press/journals (1)
-
CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
- Authors:
- Antoni Szczepanik, Marek Sierzega, Grażyna Drabik, Anna Pituch-Noworolska, Piotr Kolodziejczyk, Marek Zembala
- Academic press:
- Gastric Cancer (year: 2018, volume: 21, pages: 46031), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1007/s10120-018-0858-2 – link to the publication